Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411357 · ClinicalTrials.gov registry record · NA
Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
A NA study of Opioid Dependence and Contraceptive Usage, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
- 1
- Study location
NCT02411357: Completed NA study of Opioid Dependence and Contraceptive Usage, sponsored by University of Vermont.
NCT02411357 is a NA study of Opioid Dependence and Contraceptive Usage that has completed, run by University of Vermont. The registered enrollment target is 138 participants, below the 154-participant average among 29 other Opioid Dependence trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411357, a NA study of Opioid Dependence and Contraceptive Usage, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
- 1
- Study location
Study Summary
Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to further test a novel contraceptive management program to increase use of more effective contraceptives among opioid-maintained women at risk of unintended pregnancy.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL Incentives
- BEHAVIORAL WHO contraception protocol
Study Locations (1)
Vermont
- Vermont Center on Behavior and Health - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2015-05-05 |
| Est. Completion | 2019-09-09 |
| Phase | NA |
What the finished NCT02411357 record still lists
NCT02411357 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 154-participant average among 29 other Opioid Dependence trials with a reported enrollment target (10% lower).
The record links to 2 conditions, with Opioid Dependence appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.
NCT02411357 reports a single indexed study location in Vermont.
Frequently Asked Questions
What is clinical trial NCT02411357 about?
NCT02411357 is a clinical study titled "Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II". Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to further test a novel contraceptive management prog...
What is the current status of trial NCT02411357?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2015-05-05. Estimated completion is 2019-09-09.
What conditions does trial NCT02411357 study?
This clinical trial studies the following conditions: Opioid Dependence, Contraceptive Usage.
What interventions are being tested in trial NCT02411357?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Incentives (BEHAVIORAL), WHO contraception protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT02411357?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02411357 being conducted?
This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02411357's enrollment target sits among peer trials
138 12th of 29 higher than 18 of 29 other Opioid Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medically Complex Patients With Opioid Use Disorder Seen In Primary Care
RECRUITING · NA
-
Comparing Home, Office, and Telehealth Induction for Medication Assisted Treatment for Opioid Use Disorder
ACTIVE NOT RECRUITING · NA
-
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments
COMPLETED · NA
-
fMRI and Opioid Abstinence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI